- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- May 2024
- 194 Pages
Global
From €4749EUR$4,950USD£4,091GBP
- Report
- August 2023
- 115 Pages
Global
From €2159EUR$2,250USD£1,859GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €2399EUR$2,500USD£2,066GBP
- Report
- April 2024
- 30 Pages
Global
From €3118EUR$3,250USD£2,686GBP
- Report
- April 2024
- 30 Pages
Global
From €3118EUR$3,250USD£2,686GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4749EUR$4,950USD£4,091GBP
- Report
- January 2022
- 117 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Report
- February 2023
- 164 Pages
Global
From €7196EUR$7,500USD£6,198GBP
- Report
- February 2023
- 82 Pages
Global
From €3790EUR$3,950USD£3,264GBP
- Report
- August 2022
- 119 Pages
Global
From €4318EUR$4,500USD£3,719GBP
- Report
- April 2021
- 45 Pages
Global
€21109EUR$22,000USD£18,181GBP
- Report
- August 2022
Global
From €950EUR$990USD£818GBP
- Report
- March 2023
- 69 Pages
Global
From €6707EUR$6,990USD£5,777GBP
- Report
- August 2021
- 40 Pages
Global
From €3833EUR$3,995USD£3,302GBP
- Clinical Trials
- January 2022
- 244 Pages
Global
From €2399EUR$2,500USD£2,066GBP
- Clinical Trials
- November 2021
- 224 Pages
Global
From €2399EUR$2,500USD£2,066GBP
- Report
- November 2019
- 153 Pages
Asia Pacific
From €8631EUR$8,995USD£7,434GBP
- Report
- October 2019
- 43 Pages
Asia Pacific
From €3353EUR$3,495USD£2,888GBP
- Report
- July 2019
- 170 Pages
Global
From €10550EUR$10,995USD£9,086GBP
The RSV Drug market is a subset of the larger Respiratory Drugs market, which includes treatments for a variety of respiratory illnesses. RSV (Respiratory Syncytial Virus) is a common virus that can cause severe respiratory illness in infants and young children. RSV Drugs are used to treat the symptoms of RSV infection, such as coughing, wheezing, and difficulty breathing. These drugs can also help reduce the risk of complications from RSV, such as pneumonia and bronchiolitis.
RSV Drugs are typically administered as an inhaler or nebulizer, and may also be available in liquid or pill form. Common RSV Drugs include bronchodilators, corticosteroids, and antiviral medications. These drugs are typically prescribed by a doctor and are available over-the-counter in some countries.
Some companies in the RSV Drug market include GlaxoSmithKline, Merck, AstraZeneca, and Novartis. Show Less Read more